CAFFARRA, Paolo
 Distribuzione geografica
Continente #
EU - Europa 13.694
NA - Nord America 7.703
AS - Asia 6.108
SA - Sud America 829
AF - Africa 271
Continente sconosciuto - Info sul continente non disponibili 100
OC - Oceania 17
Totale 28.722
Nazione #
IT - Italia 9.588
US - Stati Uniti d'America 7.418
SG - Singapore 2.262
CN - Cina 1.637
VN - Vietnam 787
IE - Irlanda 652
BR - Brasile 607
SE - Svezia 581
DE - Germania 507
NL - Olanda 495
FI - Finlandia 481
HK - Hong Kong 452
UA - Ucraina 351
FR - Francia 319
TR - Turchia 283
CA - Canada 203
GB - Regno Unito 197
ZA - Sudafrica 188
BD - Bangladesh 178
IN - India 133
CH - Svizzera 124
RU - Federazione Russa 83
AR - Argentina 73
AT - Austria 70
JP - Giappone 46
PH - Filippine 46
ES - Italia 45
EC - Ecuador 44
MX - Messico 36
ID - Indonesia 35
IQ - Iraq 35
BE - Belgio 33
PK - Pakistan 29
PL - Polonia 28
RO - Romania 26
TH - Thailandia 25
TW - Taiwan 24
CO - Colombia 22
VE - Venezuela 20
MA - Marocco 18
PY - Paraguay 16
IR - Iran 15
CL - Cile 14
LT - Lituania 14
MY - Malesia 14
PE - Perù 14
AU - Australia 13
PT - Portogallo 13
SA - Arabia Saudita 13
EG - Egitto 12
KR - Corea 11
AL - Albania 9
GR - Grecia 9
JM - Giamaica 9
JO - Giordania 9
SI - Slovenia 9
UZ - Uzbekistan 9
AZ - Azerbaigian 8
CI - Costa d'Avorio 8
CZ - Repubblica Ceca 8
DZ - Algeria 8
HU - Ungheria 8
IL - Israele 8
KE - Kenya 8
UY - Uruguay 8
CR - Costa Rica 7
HN - Honduras 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
DK - Danimarca 6
SM - San Marino 6
BG - Bulgaria 5
EU - Europa 5
GY - Guiana 5
QA - Qatar 5
SC - Seychelles 5
TN - Tunisia 5
BH - Bahrain 4
ET - Etiopia 4
KG - Kirghizistan 4
KW - Kuwait 4
KZ - Kazakistan 4
LB - Libano 4
NG - Nigeria 4
NI - Nicaragua 4
NP - Nepal 4
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
SV - El Salvador 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
GP - Guadalupe 3
LK - Sri Lanka 3
NO - Norvegia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AO - Angola 2
Totale 28.602
Città #
Singapore 1.062
Milan 1.018
Ashburn 748
Rome 729
San Jose 671
Chandler 660
Dublin 641
Santa Clara 579
Jacksonville 576
Beijing 496
Hong Kong 420
Council Bluffs 300
Ho Chi Minh City 285
Naples 276
Izmir 236
Dearborn 220
Dallas 208
Boardman 202
Bologna 200
Nanjing 194
Verona 192
Turin 189
Hanoi 175
Johannesburg 175
Florence 169
Princeton 154
San Mateo 149
Parma 146
Ann Arbor 143
Padova 141
Lauterbourg 137
New York 131
Genoa 126
Los Angeles 116
Bari 109
Palermo 104
Catania 99
Wilmington 97
Toronto 92
Shanghai 76
Cagliari 72
Nanchang 72
Helsinki 69
São Paulo 68
Trieste 66
Vienna 64
Woodbridge 63
Des Moines 61
Hebei 60
Brescia 54
Padua 54
Trento 54
Shenyang 53
Moscow 49
Venice 48
Munich 47
Kunming 45
Modena 45
Jinan 43
Columbus 42
Monza 42
Pescara 42
Bremen 40
Buffalo 38
Ancona 37
Tianjin 37
Perugia 34
Frankfurt am Main 33
Hefei 33
Pavia 33
Da Nang 32
Changsha 30
Jiaxing 30
Phoenix 30
Vicenza 30
Haiphong 29
Taranto 29
Ottawa 28
Brussels 26
Mumbai 26
Brooklyn 25
Guangzhou 25
Udine 25
Houston 24
Torino 24
Busto Arsizio 23
Guidonia Montecelio 23
Genova 22
Messina 22
Pisa 22
Rio de Janeiro 22
Treviso 22
Hangzhou 21
Napoli 21
Salerno 21
Tokyo 21
Amsterdam 20
North Bergen 20
Carpi 19
Chieti 19
Totale 14.670
Nome #
Una versione abbreviata del test di Stroop: dati normativi nella popolazione italiana. 7.370
A short version of the Stroop test: Normative data in an Italian population sample 2.505
Italian norms for the Freedman version of the Clock Drawing Test. 1.143
Modified Card Sorting Test: normative data 326
ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease 226
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial 191
Brain structural substrates of semantic memory decline in Mild Cognitive Impairment. 187
The hormonal pathway to cognitive impairment in older men. 186
Visuo-spatial imagery impairment in posterior cortical atrophy: a cognitive and SPECT study. 186
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 183
The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up 177
Functional Disability in Early Alzheimer’s Disease – A Validation Study of the Italian Version of the Disability Assessment for Dementia Scale 176
ACTH/Cortisol involvement in the serotonergic disorder affecting the parkinsonian brain. 173
"Benign recurrent vertigo" and its connection with migraine. 171
The qualitative scoring MMSE pentagon test (QSPT): A new method for differentiating dementia with Lewy Body from Alzheimer's disease. 170
Abnormal serotoninergic control of prolactin and cortisol secretion in patients with seasonal affective disorder 166
A case of reversible anti-NMDA-receptor encephalitis: neuropsychological and neuroradiological features 166
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid 165
Effects of dog-assisted therapies on cognitive mnemonic capabilities in people affected by Alzheimer's disease 163
Behavioural and cognitive impairment in Parkinson-Dementia and Alzheimer type Dementia., 7, 116,1993. 160
Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorders. 159
ApoE genotype and cognitive functions in Alzheimer’s disease. Alzheimer’s Research 157
Influence of APOE status on lexical-semantic skills in Mild Cognitive Impairment 156
Benign recurrent vertigo and its connection with migraine 156
[A case of multiple cerebrovascular and migraine episodes caused by the use of oral contraceptives]. 156
A 6-month, double blind placebo-controlled trial of Eptastigmine in Alzheimer’s disease. Dement Geriatr Cogn Disord 2000;11:17-24 156
A normative study of a shorter version of the Raven Progressive Matrices 1938. 153
Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease 152
Degenerative jargon aphasia: unusual progression of logopenic/phonological progressive aphasia? 150
Clinical and Cognitive Phenotype of Mild Cognitive Impairment Evolving to Dementia with Lewy Bodies 150
Normalità e patologia delle funzioni cognitive nell’invecchiamento. 149
A multicenter Italian randomised study on early treatment of Parkinson disease:comparison of l-dopa, l-deprenyl and dopaminoagonists. Study design and short term results. 146
Efficacia di un programma di stimolazione cognitiva sulle funzioni cognitive e sul metabolismo cerebrale in pazienti con malattia di Alzheimer: dati preliminari di uno studio in aperto 144
Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders. A multicenter Italian clinical cross-sectional study on 431 patients. 142
Age at onset and SPECT imaging in Alzheimer's disease. 140
Shortened stroop color-word test: its application in normal aging and Alzheimer's disease. Neurobiol.Aging 1992;13;1;3-4 139
Rey-Osterreith Complex Figure: Normative values in an Italian population sample. 136
[Complicated migraine]. 136
Neurofunctional correlates of changes of semantic abilities in Mild Cognitive Impairment (MCI): preliminary results. 135
Explorative study on the cognitive and functional predictors of slow versus rapid disease progression in Alzhiemr's Disease. 132
Semantic Memory Impairment and Neurofunctional Alterations in Mild Cognitive Impairment 132
A Validation study of the Italian version of the disability assessment for dementia in patients with Alzheimer’s disease. 131
Increased Functional Connectivity in the Default Mode Network in Mild Cognitive Impairment: A Maladaptive Compensatory Mechanism Associated with Poor Semantic Memory Performance 128
Cognitive demand and reminders effect on prospective memory in MCI patients. 127
Clinical salience of visuospatial memory and structural brain deficits in Mild Cognitive Impairment 127
Cognitive demand and reminders effect on time-based prospective memory in amnesic Mild Cognitive Impairment (aMCI) and in healthy elderly 126
Normalità e patologia delle funzioni cognitive nell’invecchiamento. 125
[Transitory topographical amnesia]. 125
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer’s disease. 124
High specificity of MMSE pentagon scoring for diagnosis of prodromal dementia with Lewy bodies 124
Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment 123
L’utilizzo delle reti neurali nella diagnosi differenziale neuropsicologica fra la Demenza a Corpi di Lewy e la Malattia di Alzheimer. 123
Diagnostic flow chart for the atypical variants of dementia 122
Utilità e limiti della tomografia ad emissione di fotoni (SPECT) nella Malattia di Alzheimer. 121
Brief practical clinical diagnostic criteria for the neurodegenerative diseases in the elderly 121
Relationship between spatial ability, visuospatial working memory and self-assessed spatial orientation ability: a study in older adults. 120
L’attivazione cognitiva del paziente demente. In La riabilitazione neuropsicologica. Masson, Milano 1999; 385-394. 120
MRI multimodal investigation on a small cohort of patients affected by amnestic Mild Cognitive Impairment. 120
The novel GRN g.1159-1160delTG mutation is associated with behavioral variant frontotemporal dementia 119
Cognitive demand and reminders effect on prospective memory in MCI patients 117
Transient topographical amnesia. 117
Lack of seasonal variation in abnormal TSH secretion in patients with seasonal affective disorder. Biol.Psychiatry;35:36-41;1994 117
Semiquantitive assessment of regional cerebral perfusion using 99mTc HM-PAO and emission tomography. 116
Failure of oxytocin to affect motor performance in Parkinson's disease. J.Neurol.1985;(suppl.232);133 116
Il cervello non si “riposa” 116
ALEXIA WITHOUT AGRAPHIA OR HEMIANOPIA 116
Neural basis of endogenous and exogenous spatial orienting: a functional MRI study. 112
Reduction in the arginine vasopressin responses to metoclopramide and insulin-induced hypoglicemia in normal weight bulimic women. 112
Oxytocin enhances thyrotropin-releasing hormone-induced prolactin release in normal menstruating women. 112
Cervical pain and odynophagia as unusual presentation of reumathoid arthritis 112
Lack of seasonal variation in abnormal TSH secretion in patients with seasonal affective disorder 111
Transient Global Amnesia and migraine. 111
Decreased drug-cue induced attentional bias in individuals with treated and untread drug dependence 111
Oxytocin enhances thyrotropin-releasing-hormone-induced prolactin release in normal mestruting women 110
L'audizione dicotica in epilettici temporali con o senza lesioni accertabili. 110
Effect of substance P on basal and TRH-stimulated TSH release in humans 109
Lack of ACTH/cortisol and GH responses to intravenously-infused Substance P in Parkin¬son's disease. 109
Visuospatial planning and problem solving in Alzheimer's disease patients: a study with the Tower of London Test 108
Stereotypic behaviors in degenerative dementias. 108
Differenze emisferiche nei tempi di reazione semplici in pazienti depressi unipolari non-psicotici. 108
The MMSE pentagon copying is more impaired in Lewy Body dementia than Alzheimer’s Disease. 107
Tower of London Test: a comparison between conventional statistic approach and modelling based on artificial neural network in differentiating fronto-temporal dementia from Alzheimer’s disease 107
Recovery from transient global amnesia following restoration of hippocampal and fronto cingulate perfusion 106
Failure of the gamma-aminobutyric acid (GABA) derivative, baclofen, to stimulate growth hormone secretion in Parkinson's disease. 106
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. 106
Evaluation of regional cerebral blood flow using 99mTc-HM-PAO and Single Photon Emission Tomography (SPECT) 105
Osservazioni sulla percezione cutanea degli stimoli tattili figurati nell'uomo in condizioni normali. 105
Opioid control of pituitary function in parkinsonian patients before and after dopaminergic therapy 105
Reduced ACTH/cortisol responses to naloxone in men with Parkinson's disease. 105
Discriminant function analysis of Fuld's formula and WAIS subtests in different types of dementia 104
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer’s disease 104
Orienting of visual attention in Alzheimer’s disease. Its implication in favor of the interhemispheric balance. 103
Perseverative dysgraphia: a selective disorder in writing double letters 103
Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: neuroendocrine evidence in normal and parkinsonian subjects 102
Fuld's formula and WAIS subtests in differential diagnosis of dementia 101
Italian group for Lewy Body dementia (LBD): presentation of first data collected. 99
Convergent genetic and expression data implicate immunity in Alzheimer's disease 99
Neuropsychological testing during a transient global amnesia episode and its follow-up. 99
Project Cronos: multiple version of the Mini Mental State Examination ? 99
Quale trattamento per i pazienti MCI? Uno studio pilota di memory training 98
Totale 23.913
Categoria #
all - tutte 74.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022930 0 0 0 0 63 48 123 156 103 99 66 272
2022/20233.256 309 280 198 233 260 355 69 237 887 106 207 115
2023/20242.540 165 172 126 208 177 288 230 222 214 237 263 238
2024/20255.702 213 309 500 444 605 663 346 340 642 509 376 755
2025/20268.442 743 725 843 686 1.088 544 941 403 1.137 547 456 329
2026/20271.974 332 500 493 627 22 0 0 0 0 0 0 0
Totale 28.722